Empirical Finance, LLC Bristol Myers Squibb CO Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

A detailed history of Empirical Finance, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Empirical Finance, LLC holds 72,676 shares of BMY stock, worth $4.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
72,676
Previous 71,310 1.92%
Holding current value
$4.2 Million
Previous $2.96 Million 26.98%
% of portfolio
0.22%
Previous 0.19%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$39.66 - $51.75 $54,175 - $70,690
1,366 Added 1.92%
72,676 $3.76 Million
Q2 2024

Jul 30, 2024
SELL
$40.25 - $52.99 $238,763 - $314,336
-5,932 Reduced 7.68%
71,310 $2.96 Million
Q1 2024

May 06, 2024
BUY
$47.98 - $54.4 $121,053 - $137,251
2,523 Added 3.38%
77,242 $4.19 Million
Q3 2023

Nov 02, 2023
BUY
$57.89 - $64.73 $369,048 - $412,653
6,375 Added 9.33%
74,719 $4.34 Million
Q2 2023

Jul 27, 2023
BUY
$63.71 - $70.74 $485,151 - $538,685
7,615 Added 12.54%
68,344 $4.37 Million
Q1 2023

Apr 05, 2023
BUY
$65.71 - $74.53 $196,735 - $223,142
2,994 Added 5.19%
60,729 $4.21 Million
Q4 2022

Jan 24, 2023
BUY
$68.48 - $81.09 $300,764 - $356,147
4,392 Added 8.23%
57,735 $4.15 Million
Q3 2022

Nov 04, 2022
BUY
$0.13 - $76.84 $1,066 - $630,625
8,207 Added 18.18%
53,343 $3.79 Million
Q2 2022

Aug 01, 2022
BUY
$72.62 - $79.98 $169,930 - $187,153
2,340 Added 5.47%
45,136 $3.48 Million
Q1 2022

Apr 21, 2022
BUY
$61.48 - $73.72 $285,513 - $342,355
4,644 Added 12.17%
42,796 $3.13 Million
Q4 2021

Feb 04, 2022
BUY
$53.63 - $62.52 $538,498 - $627,763
10,041 Added 35.72%
38,152 $2.38 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $92,305 - $108,123
1,560 Added 5.88%
28,111 $1.66 Million
Q2 2021

Aug 10, 2021
BUY
$61.91 - $67.42 $227,209 - $247,431
3,670 Added 16.04%
26,551 $1.77 Million
Q4 2020

Feb 02, 2021
BUY
$57.74 - $65.43 $232,403 - $263,355
4,025 Added 21.35%
22,881 $1.42 Million
Q3 2020

Oct 28, 2020
BUY
$57.43 - $63.64 $1.08 Million - $1.2 Million
18,856 New
18,856 $1.14 Million
Q3 2020

Oct 26, 2020
SELL
$57.43 - $63.64 $830,322 - $920,107
-14,458 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$54.82 - $64.09 $271,304 - $317,181
4,949 Added 52.05%
14,458 $850,000
Q2 2020

Jul 20, 2020
SELL
$54.82 - $64.09 $162,541 - $190,026
-2,965 Reduced 23.77%
9,509 $850,000
Q1 2020

Apr 16, 2020
BUY
$46.4 - $67.43 $229,169 - $333,036
4,939 Added 65.55%
12,474 $695,000
Q4 2019

Jan 27, 2020
BUY
$49.21 - $64.19 $370,797 - $483,671
7,535 New
7,535 $484,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email